New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Steroids

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.steroids.2009.11.001PMID 19913568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.

  2008cited by this paper
• Physiology of folic acid in health and disease.

  2002cited by this paper
• Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception

  2002cited by this paper
• Evaluation of new pregnane derivatives as 5alpha-reductase inhibitor.

  2001cited by this paper
• Evaluation of New Pregnane Derivatives as 5α-Reductase Inhibitor

  2001cited by this paper
• Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.

  2000cited by this paper
• Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.

  2000cited by this paper
• Treatment of endometriosis with the antiprogesterone mifepristone (RU486)

  1996cited by this paper
• Molecular interactions of levonorgestrel and its 5 alpha-reduced derivative with androgen receptors in hamster flanking organs.

  1995cited by this paper
• Molecular interactions of Levonorgestrel and its 5α-reduced derivative with androgen receptors in hamster flanking organs

  1995cited by this paper
• Dual regulation of luteal progesterone production by androstenedione during spontaneous and RU486-induced luteolysis in pregnant rats.

  1995cited by this paper
• RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.

  1994cited by this paper
• Regression of uterine leiomyomata in response to the antiprogesterone RU 486.

  1993cited by this paper
• Daily administration of the progesterone antagonist RU 486 prevents implantation in the cycling guinea pig.

  1991cited by this paper
• Regulation of uterine progesterone receptors by the nonsteroidal anti-androgen hydroxyflutamide.

  1991cited by this paper
• A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat.

  1990cited by this paper
• Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.

  1990cited by this paper
• RU 486.

  1990cited by this paper
• Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation.

  1989cited by this paper
• New analogues of mifepristone with more dissociated antiprogesterone activities.

  1989cited by this paper
• Screening of anti-progestagens by receptor studies and bioassays.

  1988cited by this paper
• Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.

  1988cited by this paper
• The design and use of sex-steroid antagonists.

  1986cited by this paper
• Structural conversion of cytosolic steroid receptors by an age-dependent epididymal protease.

  1985cited by this paper
• New steroids with antiprogestational and antiglucocorticoid activities.

  1984cited by this paper
• Purification of a human progesterone receptor.

  1981cited by this paper
• Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Reproductive Biology and Endocrinology Open Access Serial Analysis of Gene Expression Reveals Differential Expression between Endometriosis and Normal Endometrium. Possible Roles for Axl and Shc1 in the Pathogenesis of Endometriosis

  year unknowncited by this paper

• Current Progresses and Trends in the Development of Progesterone Receptor Modulators.

  2016cites this paper
• Recent advances in structure of progestins and their binding to progesterone receptors

  2015cites this paper
• BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.

  2013cites this paper
• Biological Evaluation of Androstene Derivatives

  2013cites this paper
• Synthesis and characterization of new aromatic esters based on 4,16-pregnadiene-6,20-dione skeleton

  2010cites this paper